Axon Enterprise Shares Fall on Upped Skydio Investment, Guidance Cut From Delayed Deployments

What happened

Axon said it expects annual revenue growth of about 30%, or $3.61 billion to $3.63 billion, down from its prior forecast of 32% to 34%. It removed three Federal Dedrone deployments worth around $130 million from this year’s outlook because they are no longer on track to happen this year.

Confirmed

Global impact / market context

The delayed deployments reduce revenue Axon expects to record this year, directly lowering its forecast and potentially postponing customer payments. The lower outlook may also shape investor expectations for growth, while quarterly adjusted earnings of $1.72 per share fell short of analysts’ $1.89 expectation.

Analyst inference

The article reports Axon shares fell 10% to $345.50 in after-hours trading, after closing down 9.8% at $382.56; the stock was down 33% this year. Axon’s revenue outlook is also below analysts’ $3.71 billion estimate.

Confirmed

What to watch

1. Whether the three Federal Dedrone deployments are rescheduled, and when Axon expects to recognize their roughly $130 million in revenue, will clarify the timing of the shortfall. Analyst inference
2. Axon’s next revenue updates can show whether the revised annual range of $3.61 billion to $3.63 billion remains achievable as delayed deployments affect customer delivery schedules. Analyst inference
3. The company reported third-quarter adjusted earnings of $1.72 per share, below analysts’ $1.89 expectation; future results will indicate whether that gap persists. Confirmed

Evidence

• Original source link unavailable